{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Forêts : Questions médicales les plus fréquentes",
"headline": "Forêts : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Forêts : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-09",
"dateModified": "2025-03-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Forêts"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Écosystème",
"url": "https://questionsmedicales.fr/mesh/D017753",
"about": {
"@type": "MedicalCondition",
"name": "Écosystème",
"code": {
"@type": "MedicalCode",
"code": "D017753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230.124"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Forêt pluviale",
"alternateName": "Rainforest",
"url": "https://questionsmedicales.fr/mesh/D065947",
"about": {
"@type": "MedicalCondition",
"name": "Forêt pluviale",
"code": {
"@type": "MedicalCode",
"code": "D065947",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230.124.343.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Taïga",
"alternateName": "Taiga",
"url": "https://questionsmedicales.fr/mesh/D066188",
"about": {
"@type": "MedicalCondition",
"name": "Taïga",
"code": {
"@type": "MedicalCode",
"code": "D066188",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230.124.343.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Forêts",
"alternateName": "Forests",
"code": {
"@type": "MedicalCode",
"code": "D065928",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jin Wu",
"url": "https://questionsmedicales.fr/author/Jin%20Wu",
"affiliation": {
"@type": "Organization",
"name": "School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong, China."
}
},
{
"@type": "Person",
"name": "Naomi B Schwartz",
"url": "https://questionsmedicales.fr/author/Naomi%20B%20Schwartz",
"affiliation": {
"@type": "Organization",
"name": "Department of Geography, University of British Columbia, 1984 West Mall, Vancouver, British Columbia, V6T 1Z2, Canada."
}
},
{
"@type": "Person",
"name": "María Uriarte",
"url": "https://questionsmedicales.fr/author/Mar%C3%ADa%20Uriarte",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology Evolution and Environmental Biology, Columbia University, 1200 Amsterdam Avenue, New York, New York, 10027, USA."
}
},
{
"@type": "Person",
"name": "Stuart J Davies",
"url": "https://questionsmedicales.fr/author/Stuart%20J%20Davies",
"affiliation": {
"@type": "Organization",
"name": "Forest Global Earth Observatory, Smithsonian Tropical Research Institute, Washington, District of Columbia, USA."
}
},
{
"@type": "Person",
"name": "Primrose J Boynton",
"url": "https://questionsmedicales.fr/author/Primrose%20J%20Boynton",
"affiliation": {
"@type": "Organization",
"name": "Biology Department Wheaton College Norton MA USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of the national hepatitis B immunization program in China: a modeling study.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36221140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40249-022-01032-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.",
"datePublished": "2024-06-10",
"url": "https://questionsmedicales.fr/article/38857859",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2357439"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36503856",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2022.11.074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigation of non-National Immunization Program vaccination intentions in rural areas of China.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37542236",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16390-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.",
"datePublished": "2023-10-31",
"url": "https://questionsmedicales.fr/article/37956381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.17886"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Environnement",
"item": "https://questionsmedicales.fr/mesh/D004777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Écosystème",
"item": "https://questionsmedicales.fr/mesh/D017753"
},
{
"@type": "ListItem",
"position": 5,
"name": "Forêts",
"item": "https://questionsmedicales.fr/mesh/D065928"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Forêts - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Forêts",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Forêts",
"description": "Comment évaluer la santé d'une forêt ?\nQuels indicateurs montrent une déforestation ?\nComment détecter les maladies des arbres ?\nQuels outils mesurent la biodiversité forestière ?\nComment évaluer l'impact des incendies sur les forêts ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Forêts",
"description": "Quels signes indiquent une forêt en déclin ?\nComment reconnaître une invasion d'espèces exotiques ?\nQuels symptômes montrent un stress hydrique dans les forêts ?\nQuels signes indiquent une pollution forestière ?\nComment identifier les effets du changement climatique sur les forêts ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Forêts",
"description": "Comment prévenir la déforestation ?\nQuelles actions protègent les forêts contre les incendies ?\nComment limiter l'impact des changements climatiques sur les forêts ?\nQuelles stratégies protègent la biodiversité forestière ?\nComment sensibiliser à la protection des forêts ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Forêts",
"description": "Quelles méthodes restaurent une forêt dégradée ?\nComment traiter les maladies des arbres ?\nQuelles pratiques favorisent la biodiversité forestière ?\nComment gérer les espèces envahissantes ?\nQuelles techniques améliorent la résilience des forêts ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Forêts",
"description": "Quelles sont les conséquences de la déforestation ?\nComment la pollution affecte-t-elle les forêts ?\nQuels risques posent les espèces envahissantes ?\nQuelles sont les répercussions des incendies de forêt ?\nComment le changement climatique impacte-t-il les forêts ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Forêts",
"description": "Quels facteurs augmentent le risque de déforestation ?\nComment le changement climatique influence-t-il les forêts ?\nQuels sont les impacts de l'urbanisation sur les forêts ?\nComment les pratiques agricoles affectent-elles les forêts ?\nQuels risques posent les maladies des arbres ?",
"url": "https://questionsmedicales.fr/mesh/D065928?mesh_terms=Immunization+Programs&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la santé d'une forêt ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On évalue la diversité des espèces, la qualité du sol et la présence de maladies."
}
},
{
"@type": "Question",
"name": "Quels indicateurs montrent une déforestation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réduction de la couverture forestière et l'augmentation des terres agricoles sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment détecter les maladies des arbres ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des symptômes comme le flétrissement, les taches foliaires et la mortalité des branches aide au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent la biodiversité forestière ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les inventaires floristiques et faunistiques sont utilisés pour mesurer la biodiversité."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des incendies sur les forêts ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "On analyse la superficie brûlée, la régénération des espèces et les changements dans l'écosystème."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une forêt en déclin ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution de la biodiversité, des arbres malades et une érosion accrue sont des signes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une invasion d'espèces exotiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition soudaine d'espèces non indigènes et leur domination sur les espèces locales sont des signes."
}
},
{
"@type": "Question",
"name": "Quels symptômes montrent un stress hydrique dans les forêts ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les feuilles jaunissent, tombent prématurément et les arbres montrent un flétrissement."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une pollution forestière ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La décoloration des feuilles, la mortalité des arbres et la présence de dépôts toxiques sont des signes."
}
},
{
"@type": "Question",
"name": "Comment identifier les effets du changement climatique sur les forêts ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe des changements dans la phenologie, la distribution des espèces et la mortalité des arbres."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déforestation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mise en place de lois, la sensibilisation et la promotion de l'agriculture durable sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles actions protègent les forêts contre les incendies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La création de pare-feux, la gestion des combustibles et l'éducation du public sont des actions préventives."
}
},
{
"@type": "Question",
"name": "Comment limiter l'impact des changements climatiques sur les forêts ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réduction des émissions de gaz à effet de serre et l'adaptation des pratiques forestières sont cruciales."
}
},
{
"@type": "Question",
"name": "Quelles stratégies protègent la biodiversité forestière ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La création de réserves naturelles et la mise en œuvre de lois de protection sont des stratégies efficaces."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à la protection des forêts ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes éducatives, des programmes scolaires et des événements communautaires sensibilisent le public."
}
},
{
"@type": "Question",
"name": "Quelles méthodes restaurent une forêt dégradée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La reforestation, l'enrichissement et la gestion durable des ressources sont des méthodes efficaces."
}
},
{
"@type": "Question",
"name": "Comment traiter les maladies des arbres ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements phytosanitaires, la taille des branches malades et la sélection d'espèces résistantes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles pratiques favorisent la biodiversité forestière ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La création de corridors écologiques et la protection des habitats naturels favorisent la biodiversité."
}
},
{
"@type": "Question",
"name": "Comment gérer les espèces envahissantes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'élimination manuelle, l'utilisation de biocides et la restauration des habitats sont des stratégies."
}
},
{
"@type": "Question",
"name": "Quelles techniques améliorent la résilience des forêts ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La diversification des espèces et la gestion adaptative des forêts améliorent leur résilience."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences de la déforestation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "La perte de biodiversité, l'érosion des sols et le changement climatique sont des conséquences majeures."
}
},
{
"@type": "Question",
"name": "Comment la pollution affecte-t-elle les forêts ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution de l'air et du sol peut entraîner des maladies des plantes et la perte de biodiversité."
}
},
{
"@type": "Question",
"name": "Quels risques posent les espèces envahissantes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les espèces envahissantes peuvent réduire la biodiversité et perturber les écosystèmes locaux."
}
},
{
"@type": "Question",
"name": "Quelles sont les répercussions des incendies de forêt ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les incendies peuvent détruire des habitats, libérer du carbone et affecter la qualité de l'air."
}
},
{
"@type": "Question",
"name": "Comment le changement climatique impacte-t-il les forêts ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il provoque des changements dans la distribution des espèces, des sécheresses et des maladies des arbres."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déforestation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'expansion agricole, l'urbanisation et l'exploitation forestière non durable sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment le changement climatique influence-t-il les forêts ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il augmente la fréquence des événements extrêmes comme les sécheresses et les tempêtes, affectant les forêts."
}
},
{
"@type": "Question",
"name": "Quels sont les impacts de l'urbanisation sur les forêts ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'urbanisation entraîne la fragmentation des habitats et la perte de biodiversité forestière."
}
},
{
"@type": "Question",
"name": "Comment les pratiques agricoles affectent-elles les forêts ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pratiques agricoles intensives peuvent entraîner la déforestation et la dégradation des sols."
}
},
{
"@type": "Question",
"name": "Quels risques posent les maladies des arbres ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies peuvent se propager rapidement, entraînant la mortalité des arbres et la perte de biodiversité."
}
}
]
}
]
}
Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries...
We constructed an expanded Susceptible-Exposed-Infectious-Recovered (SEIR) model and decision tree-Markov model to estimate the epidemic of HBV in China, assess the feasibility of 2030 Elimination Goa...
Between 1990 and 2020, the number of chronic HBV infections decreased by 33.9%. The current status quo would lead to 55.73 million infections (3.95% prevalence) in 2030, compared to 90.63 million (6.4...
Our findings proved the HBV vaccination has demonstrated a substantial positive impact on controlling the epidemic of HBV in terms of effectiveness and economy after about 30 years of implementation o...
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...
Globally, rotavirus is a leading cause of severe acute gastroenteritis among children aged under 5 years and has a significant economic cost. Currently, rotavirus vaccines are only included in the pri...
A decision tree Markov model was constructed to evaluate the cost-benefit of universal immunization with three doses of rotavirus vaccine for a 2019 birth cohort of Chinese children. Costs of the univ...
For the 2019 birth cohort of Chinese infants, inclusion of RotaTeq in NIP was estimated to prevent 5,677,911 cases of rotavirus infection, with net savings of $1.1 billion in total societal costs. A c...
Introducing rotavirus vaccine into the China NIP would have significant costs from a societal perspective at the current private market price....
China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee...
A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac...
This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ...
Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...
Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a...
The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi...
While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect...
The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...
Despite widespread adoption of decentralization reforms, the impact of decentralization on health system attributes, such as access to health services, responsiveness to population health needs, and e...
This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a...
A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent...
Incorporating the hexavalent vaccine would result in a 15.5% net increase in healthcare budget expenditure ($48,281,706 vs $55,744,653). Vaccination costs would increase by 54.1%, whereas logistical a...
Despite of the significant reduction of logistical and adverse reaction costs, including the hexavalent vaccine into the National Immunization Program of Peru in place of the current vaccination schem...
This article analyzes the films produced and broadcast between 1976 and 1978 by the National Agency and the Public Relations Office (ARP) for the campaign to publicize the mandatory vaccination that w...
The introduction of Expanded Program on Immunization (EPI) and the availability of vaccines have contributed to significant reduction in morbidity and mortality rate, particularly among infants and ch...
The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization se...
We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine...
Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These...